WHO ICTRP trial
Intranasal steroids alone and in combination with levocetirizine, and/or…
CTRI/2025/01/079369 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/01/079369 |
|---|---|
| Public title | Intranasal steroids alone and in combination with levocetirizine, and/or montelukast for moderate to severe allergic rhinitis in children |
| Scientific title | Intranasal steroids alone and in combination with levocetirizine, and/or montelukast for moderate to severe allergic rhinitis in children: a randomized controlled trial - NIL |
| Primary sponsor | AIIMS NEW DELHI |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: J309- Allergic rhinitis, unspecified |
| Interventions | Intervention1: Combination therapy of Intranasal steroid plus montelukast or/and Levocetrizine: Group 2: Intranasal steroid plus montelukast syrup Group 3: Intranasal steroid plus Levocetrizine Group 4: Intranasal steroid plus montelukast… |
| Registration date | Jan 24, 2025 |
| Target size | 64 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: